Advertise
NEWSLETTER
HCW Biologics wins key U.S....
Scribe Therapeutics starts ...
Rapalogix Health opens Prin...
China approves Leqembi subc...
FibroBiologics granted US p...
HCW Biologics wins key U.S....
Scribe Therapeutics starts ...
Rapalogix Health opens Prin...
China approves Leqembi subc...
FibroBiologics granted US p...
Mogling Bio

Mogling Bio secures additional funding to advance rejuvenation tech

MoglingBio closes seed investment round with Kizoo Technology Capital.

Kizoo invests in rejuvenation startup Mogling Bio

Mogling Bio is rejuvenating older stem cells to target age-related disease and restore the function of the aging immune system.

Is aging a question of order vs disorder?

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form